Zefiro Methane Corp.
ZEFIF
$0.2568
-$0.046-15.19%
| Weiss Ratings | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -27.36% | |||
| 30-Day Total Return | -32.42% | |||
| 60-Day Total Return | -53.33% | |||
| 90-Day Total Return | -48.64% | |||
| Year to Date Total Return | -47.88% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -80.25% | |||
| 52-Week Low % Change | 62.94% | |||
| Price | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.30 | |||
| 52-Week Low Price | $0.16 | |||
| 52-Week Low Price (Date) | Oct 25, 2024 | |||
| 52-Week High Price (Date) | Jul 08, 2024 | |||
| Valuation | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 23.01M | |||
| Enterprise Value | 36.59M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | 449.06% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.52 | |||
| Price/Book (Q) | 3.49 | |||
| Enterprise Value/Revenue (TTM) | 1.03 | |||
| Price | $0.26 | |||
| Enterprise Value/EBITDA (TTM) | -10.65 | |||
| Enterprise Value/EBIT | -5.04 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 72.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800-274-9334 | |||
| Address | 1075 West Georgia Street Vancouver, BC V6E 3C9 | |||
| Website | zefiromethane.com | |||
| Country | Canada | |||
| Year Founded | 2018 | |||
| Profitability | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -20.49% | |||
| Profit Margin | -28.14% | |||
| Management Effectiveness | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -17.97% | |||
| Return on Equity | -- | |||
| Income Statement | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 35.41M | |||
| Total Revenue (TTM) | 35.41M | |||
| Revenue Per Share | $0.49 | |||
| Gross Profit (TTM) | 9.89M | |||
| EBITDA (TTM) | -3.44M | |||
| EBIT (TTM) | -7.26M | |||
| Net Income (TTM) | -9.97M | |||
| Net Income Avl. to Common (TTM) | -9.97M | |||
| Total Revenue Growth (Q YOY) | 8.93% | |||
| Earnings Growth (Q YOY) | -133.80% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | -100.97% | |||
| Balance Sheet | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 282.10K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 6.39M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.39M | |||
| Current Ratio (Q) | 0.595 | |||
| Book Value Per Share (Q) | $0.07 | |||
| Total Assets (Q) | 24.62M | |||
| Total Current Liabilities (Q) | 10.75M | |||
| Total Debt (Q) | 13.91M | |||
| Total Liabilities (Q) | 19.23M | |||
| Total Common Equity (Q) | 5.39M | |||
| Cash Flow | ZEFIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.92M | |||
| Cash from Financing (TTM) | 4.08M | |||
| Net Change in Cash (TTM) | -543.00K | |||
| Levered Free Cash Flow (TTM) | -2.24M | |||
| Cash from Operations (TTM) | -1.81M | |||
